The use of cimetidine to reduce dapsone-dependent methaemoglobinaemia in dermatitis herpetiformis patients
about
Celiac disease and autoimmunity: review and controversiesMethemoglobinemiaSummary of information on human CYP enzymes: human P450 metabolism data.Clinical outcomes and kinetics of propanil following acute self-poisoning: a prospective case series.Efficacy of dapsone in the treatment of pemphigus and pemphigoid: analysis of current data.How Clinically Relevant is Dapsone-related Peripheral Neuropathy?: An Overview of Available Data with Emphasis on Clinical Recognition.Metabolism-based drug interactions involving oral azole antifungals in humans.Dapsone-induced methemoglobinemia: a primer for clinicians.Dermatitis herpetiformis.Dapsone in dermatology and beyondPharmacokinetic considerations in clinical toxicology: clinical applications.Dapsone and azole interactions: A clinical perspective.Dapsone: modes of action, toxicity and possible strategies for increasing patient tolerance.Dapsone induced methemoglobinemia in a patient with glioblastoma.Periodontal implications: mucocutaneous disorders.Dapsone-induced methemoglobinemia: "Saturation gap"-The key to diagnosis.Dapsone-induced methemoglobinemia in renal transplant recipients: more prevalent than previously thought.Desquamative gingivitis associated with IgG/IgA pemphigoid presents a challenging diagnosis and treatment: a case report.The effect of ethyl pyruvate on dapsone-induced methemoglobinemia in rats.Very late recovery of dapsone-induced methemoglobinemia.Cimetidine and dapsone-mediated methaemoglobinaemia.Dapsone-induced acute pancreatitis.Dapsone-induced methemoglobinemia.Therapeutic effect of ascorbic acid on dapsone-induced methemoglobinemia in rats
P2860
Q28290840-22826C66-ECA0-4C60-B34B-70B793525CF2Q28347367-D99A1A8F-F0D3-4BA8-8509-FA1A0E378C3FQ32103802-BB958F08-B089-4A52-B8A3-EBF5FAD0391FQ33409751-4D2CB5BD-A610-4488-B49F-908EA5FDCD22Q33510238-1CA9DC42-597B-4580-BF40-A620D16D0B4DQ33666873-6A391445-45C9-4E99-B347-8A71AE6F3BB0Q33719828-A934AE4C-E875-44DA-A18F-78FC56A7D339Q33996554-ABF67A9E-6514-4DF6-857D-A3280E7F2B04Q34218376-97EFC10A-0DE2-4F23-9EA5-8B23C823D9FDQ34390020-BA9197A8-AE40-4DC4-9F63-AC9407A3346AQ36964648-9FC5FCC2-28F9-4E54-AEF4-8A5591E263E9Q39450909-8C2B0799-2993-49D0-A2DE-DD5B320AC5D5Q40785532-FB9348CB-456F-4E23-B322-FEE407BAB994Q40892234-66804CCB-59C0-416A-9B90-F85B59B547DAQ41444884-BF79693A-E640-4B6D-8D8D-A55BE69557F3Q41858316-1CAE51A9-31BE-4787-B060-F60A2F9BB7EDQ42241210-F269119D-1BCF-48C2-83FE-B8C3FE874C56Q45283556-103BFA2E-BA95-429E-93DC-DB4DAE33EE49Q46343749-7A80C6F4-57E9-4D60-A2AF-F8F47B706CB4Q46597559-60E5CC1C-2D89-42F3-81AC-25B43937DDE7Q46959382-DDC1C44F-44F7-451A-8EE2-C66B1BE47BDAQ47968071-02276C73-0B88-491B-87BB-DE904CC2D867Q50524075-6D95CA14-41DD-40E7-9797-EE9EF4959B85Q57121198-5A253483-B176-4EC8-A72B-41D30EF2E091
P2860
The use of cimetidine to reduce dapsone-dependent methaemoglobinaemia in dermatitis herpetiformis patients
description
1992 nî lūn-bûn
@nan
1992 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
The use of cimetidine to reduc ...... matitis herpetiformis patients
@ast
The use of cimetidine to reduc ...... matitis herpetiformis patients
@en
The use of cimetidine to reduc ...... matitis herpetiformis patients
@nl
type
label
The use of cimetidine to reduc ...... matitis herpetiformis patients
@ast
The use of cimetidine to reduc ...... matitis herpetiformis patients
@en
The use of cimetidine to reduc ...... matitis herpetiformis patients
@nl
prefLabel
The use of cimetidine to reduc ...... matitis herpetiformis patients
@ast
The use of cimetidine to reduc ...... matitis herpetiformis patients
@en
The use of cimetidine to reduc ...... matitis herpetiformis patients
@nl
P2093
P2860
P1476
The use of cimetidine to reduc ...... matitis herpetiformis patients
@en
P2093
A M Breckenridge
J L Verbov
L E Rhodes
M D Coleman
P S Friedmann
P2860
P304
P356
10.1111/J.1365-2125.1992.TB04131.X
P407
P577
1992-09-01T00:00:00Z